Showing results (61-70 of 144) with videos related to
Sort By:
Pageof 15
Plos One|June 14, 2013
Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferonFranz J Zemp, Brienne A McKenzie, Xueqing Lun, et al.Plos One|June 14, 2013
Myxoma virus infection promotes NK lysis of malignant gliomas in vitro and in vivoHenry Ogbomo, Franz J Zemp, Xueqing Lun, et al.Cell Host & Microbe|February 19, 2013
Neutrophils recruited to sites of infection protect from virus challenge by releasing neutrophil extracellular trapsCraig N Jenne, Connie H Y Wong, Franz J Zemp, et al.Journal of Clinical Medicine|July 2, 2020
Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade GliomaDaniel J Glazar, G Daniel Grass, John A Arrington, et al.Frontiers in Oncology|March 21, 2022
Improving Brain Metastases Outcomes Through Therapeutic Synergy Between Stereotactic Radiosurgery and Targeted Cancer TherapiesSebastian Rubino, Daniel E Oliver, Nam D Tran, et al.Journal of Neuro-Oncology|March 4, 2022
Evolving management of HER2+ breast cancer brain metastases and leptomeningeal diseaseMatthew N Mills, Whitney King, Aixa Soyano, et al.Journal of Neuro-Oncology|April 26, 2006
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiationVictor A Levin, Surasak Phuphanich, W K Alfred Yung, et al.Neuro-Oncology|January 22, 2015
In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cellsBrienne A McKenzie, Franz J Zemp, Alexandra Pisklakova, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Altered subcellular localization and low frequency of mutations of ING1 in human brain tumorsDiego Vieyra, Donna L Senger, Tatsuya Toyama, et al.Plos Biology|December 11, 2008
Gamma-secretase represents a therapeutic target for the treatment of invasive glioma mediated by the p75 neurotrophin receptorLiMei Wang, Jennifer J Rahn, XueQing Lun, et al.Pageof 15